Connor, Clark & Lunn Investment Management Ltd.

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1596800 VANCOUVER, A1

Position in FULC

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$5,650,366

-$936,317 QoQ

Shares Held

736,684

+26.5% QoQ

Ownership

1.11%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#25

of 168 holders

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $706,217,774 across 100 Biotechnology names. FULC ranks #34 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	251,711	$112,399,029
2	IONS	Ionis Pharmaceuticals Inc	874,089	$65,635,343
3	ARWR	Arrowhead Pharmaceuticals, Inc.	836,981	$52,478,708
4	MIRM	Mirum Pharmaceuticals, Inc.	479,476	$44,293,992
5	REGN	Regeneron Pharmaceuticals, Inc.	32,164	$24,851,192
6	AXSM	Axsome Therapeutics, Inc.	134,792	$22,782,543
7	SRPT	Sarepta Therapeutics, Inc.	1,019,951	$22,194,133
8	TERN	Terns Pharmaceuticals, Inc.	384,681	$20,280,382

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,650,366	736,684	+26.5%	Shares	Sole	2026-05-11
2025-12-31	$6,586,683	582,377	+51.6%	Shares	Sole	2026-02-10
2025-09-30	$3,534,069	384,138	+12.1%	Shares	Sole	2025-11-13
2025-06-30	$2,356,723	342,547	+57.3%	Shares	Sole	2025-08-07
2025-03-31	$627,117	217,749	-40.8%	Shares	Sole	2025-05-12
2024-12-31	$1,727,691	367,594	+176.8%	Shares	Sole	2025-02-10
2024-09-30	$474,038	132,784	—	Shares	Sole	2024-11-08
No filing history on record for this holder in this stock.